Abstract
The activity of neural progenitor cells (NPCs) is regulated by various humoral factors. Although prostaglandin (PG) D2 is known to mediate various physiological brain functions such as sleep, its actions on NPCs have not been fully understood. In the process of investigating the effects of PGD2 on NPCs, we found that 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), an endogenous metabolite of PGD2, exhibits a novel regulation of the proliferation of NPCs derived from mouse hippocampus. 15d-PGJ2 showed biphasic effects on epidermal growth factor-induced proliferation of NPCs; facilitation at low concentrations (∼0.3 μM) and suppression at higher concentrations (0.5–10 μM) in vitro. 2-Chloro-5-nitrobenzanilide (GW9662), an inhibitor of peroxisome proliferator-activated receptor γ, known to be a molecular target for 15d-PGJ2, failed to abolish the effects of 15d-PGJ2. 9,10-dihydro-15d-PGJ2 (CAY10410), a structural analog of 15d-PGJ2 lacking the electrophilic carbon in the cyclopentenone ring, did not show 15d-PGJ2-like actions. Treatment with 15d-PGJ2 increased the levels of reactive oxygen species and decreased endogenous GSH levels. Furthermore, supplementation with a membrane-permeable analog of glutathione, GSH ethyl ester (2 mM), diminished the biphasic effects of 15d-PGJ2. Finally, cell division in the dentate gyrus of postnatal mice was increased by injection of low-dose (1 ng i.c.v.) 15d-PGJ2 and suppressed by high-dose (30 ng) 15d-PGJ2. These results suggest that 15d-PGJ2 regulates the proliferation of NPCs via its electrophilic nature, which enables covalent binding to molecules such as GSH.
Footnotes
↵ The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas-Molecular Brain Science-from the Ministry of Education, Culture, Sports, Science and Technology of Japan (2002) and by the Nishinomiya Basic Research Fund (Japan).
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.109.061010.
-
ABBREVIATIONS:
- NPC
- neural progenitor cell
- DG
- dentate gyrus
- PG
- prostaglandin
- 15d-PGJ2
- 15-deoxy-Δ12,14-prostaglandin J2
- PPAR
- peroxisome proliferator-activated receptor
- ROS
- reactive oxygen species
- MHM
- media-hormone mix
- EGF
- epidermal growth factor
- BWA868C
- 3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxo-1-(phenylmethyl)-4-imidazolidineheptanoic acid
- CAY10410
- 9,10-dehydro-15-deoxy-Δ12,14-prostaglandin J2
- GW9662
- 2-chloro-5-nitrobenzanilide
- BrdU
- bromodeoxyuridine
- IgG
- immunoglobulin G
- H2DCFDA
- 2′,7′-dichlorodihydrofluorescein diacetate
- GFAP
- anti-glial fibrillary acidic protein
- GSH-EE
- GSH reduced ethyl ester
- WST-8; TUNEL
- terminal deoxynucleotidyl transferase dUTP nick-end labeling
- PPAR
- peroxisome proliferator-activated receptor
- PMA
- phorbol 12,13-myristate acetate
- PFA
- paraformaldehyde
- PBS
- phosphate-buffered saline
- PBSGT
- PBS containing 1% normal goat serum and 0.3% Triton X-100
- PB
- phosphate buffer
- ANOVA
- analysis of variance
- MCI-186
- edaravone
- DP1
- prostaglandin D2 receptor type 1
- DP2
- prostaglandin D2 receptor type 2
- Trx
- thioredoxin
- LPS
- lipopolysaccharide.
- Received September 14, 2009.
- Accepted January 19, 2010.
- Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|